CLINICAL_TRIALS ClinicalTrials.gov record update

Multisite Open-label Randomized Phase II Clinical Trial in Newly Diagnosed Glioblastoma Treated by Concurrent Temoradiation and Adjuvant Temozolomide +/- Ultrasound-induced Blood Brain Barrier Opening.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04614493
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:44.660777+00:00
Published At: 2022-03-29T00:00:00+00:00
Record Updated At: 2022-03-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Initial Radiological Diagnosis Eligible for Tumor Resection", "Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)", "Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-03-29"
protocolSection.identificationModule.nctId: "NCT04614493"
protocolSection.identificationModule.officialTitle: "Multisite Open-label Randomized Phase II Clinical Trial in Newly Diagnosed Glioblastoma Treated by Concurrent Temoradiation and Adjuvant Temozolomide +/- Ultrasound-induced Blood Brain Barrier Opening."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.